Analyze factors that influence pharmacokinetic and pharmacodynamic processes in clients requiring therapy for pain

Assess client factors and history to develop personalized therapy plans for clients with pain

Analyze factors that influence pharmacokinetic and pharmacodynamic processes in clients requiring therapy for pain

Evaluate efficacy of treatment plans for clients presenting for pain therapy
Analyze ethical and legal implications related to prescribing therapy for clients with pain
Learning Resources
Note: To access this week’s required library resources, please click on the link to the Course Readings List, found in the Course Materials section of your Syllabus.

**Factors Influencing Pharmacokinetic and Pharmacodynamic Processes in Pain Therapy:**

 

**Physiological Factors:** Variations in a client’s age, gender, weight, and overall health can impact how their body metabolizes and responds to pain medications. For example, older adults may experience slower metabolism and reduced renal function, affecting drug clearance and increasing the risk of adverse effects.

 

**Genetic Factors:** Genetic variations can influence the activity of drug-metabolizing enzymes and drug transporters, leading to inter-individual differences in drug response. Pharmacogenomic testing can help identify genetic factors that may affect the efficacy and safety of pain medications.

 

**Drug Interactions:** Concurrent use of multiple medications can alter the pharmacokinetics and pharmacodynamics of pain therapy. Drug-drug interactions may result in increased or decreased drug concentrations, leading to therapeutic failure or toxicity. Health care providers should carefully assess a client’s medication regimen to minimize the risk of adverse interactions.

 

**Liver and Kidney Function:** Hepatic and renal impairment can significantly impact the metabolism and elimination of pain medications. Clients with liver or kidney dysfunction may require dosage adjustments or alternative medications to avoid drug accumulation and toxicity.

 

**Psychosocial Factors:** Psychological factors such as anxiety, depression, and stress can influence pain perception and response to therapy. Addressing psychosocial factors alongside pharmacological interventions may enhance the effectiveness of pain management strategies.

 

**Evaluation of Treatment Plans for Pain Therapy:**

 

**Pain Relief:** The primary goal of pain therapy is to alleviate pain and improve the client’s quality of life. Treatment plans should be evaluated based on their ability to provide adequate pain relief while minimizing adverse effects.

 

**Functional Improvement:** Effective pain management should enable clients to regain or maintain functional abilities, such as mobility, sleep quality, and participation in daily activities. Treatment plans should be assessed for their impact on functional outcomes and overall well-being.

 

**Safety Profile:** Evaluation of treatment plans should consider the safety profile of pain medications, including the risk of addiction, tolerance, dependence, and adverse effects. Health care providers should monitor clients for signs of medication misuse or abuse and adjust treatment accordingly.

 

**Patient Satisfaction:** Client satisfaction with pain therapy is an important measure of treatment efficacy. Assessing client preferences, adherence to treatment, and satisfaction with pain relief can inform the ongoing management of pain and optimize treatment outcomes.

 

**Ethical and Legal Implications of Pain Therapy Prescribing:**

 

**Informed Consent:** Health care providers have a legal and ethical obligation to obtain informed consent from clients before initiating pain therapy. Clients should be fully informed about the risks, benefits, alternatives, and expected outcomes of treatment options.

 

**Prescription Drug Monitoring Programs (PDMPs):** Health care providers must adhere to legal requirements related to the prescription and monitoring of controlled substances for pain management. PDMPs help prevent prescription drug abuse and diversion by monitoring the prescribing and dispensing of controlled substances.

 

**Opioid Prescribing Guidelines:** Health care providers should follow evidence-based guidelines and best practices for opioid prescribing to minimize the risk of opioid misuse, overdose, and diversion. This includes conducting thorough assessments, implementing risk mitigation strategies, and monitoring clients for signs of opioid-related harms.

 

**Multidisciplinary Collaboration:** Ethical pain management involves collaboration among health care professionals, including physicians, pharmacists, psychologists, and social workers, to address the complex needs of clients with chronic pain. Multidisciplinary teams can provide comprehensive care, promote shared decision-making, and optimize treatment outcomes while minimizing risks associated with pain therapy.

Required Readings

Note: All Stahl resources can be accessed through the Walden Library using this link. This link will take you to a log-in page for the Walden Library. Once you log into the library, the Stahl website will appear.

Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press.
To access the following chapters, click on the Essential Psychopharmacology, 4th ed tab on the Stahl Online website and select the appropriate chapter. Be sure to read all sections on the left navigation bar for each chapter. Chapter 10, “Chronic Pain and Its Treatment”

Stahl, S. M., & Ball, S. (2009a). Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press.
To access the following chapter, click on the Illustrated Guides tab and then the Chronic Pain and Fibromyalgia tab. Chapter 5, “Pain Drugs”

Stahl, S. M. (2014b). The prescriber’s guide (5th ed.). New York, NY: Cambridge University Press.
To access information on the following medications, click on The Prescriber’s Guide, 5th ed tab on the Stahl Online website and select the appropriate medication.
Review the following medications:
For insomnia amitriptyline
amoxapine
carbamazepine
clomipramine
clonidine (adjunct)
desipramine
dothiepin
doxepin
duloxetine
gabapentin
imipramine
lamotriginelevetiracetam
lofepramine
maprotiline
memantine
milnacipran
nortriptyline
pregabalin
tiagabine
topiramate
trimipramine
valproate (divalproex)
zonisamide

AMERICAN PSYCHIATRIC ASSOCIATION. (2013). DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS (5TH ED.). WASHINGTON, DC: AUTHOR.
NOTE: RETRIEVED FROM WALDEN LIBRARY DATABASES.

National Institute of Neurological Disorders and Stroke. (2016). Pain: Hope through research. Retrieved from http://www.ninds.nih.gov/disorders/chronic_pain/de…

Required Media

Laureate Education (2016a). Case study: A Caucasian man with hip pain [Interactive media file]. Baltimore, MD: Author
Note: This case study will serve as the foundation for this week’s Assignment.

To prepare for this Assignment:

Review this week’s Learning Resources. Consider how to assess and treat clients requiring therapy for pain and sleep/wake disorders.

The Assignment

Examine Case Study: A Caucasian Man With Hip Pain. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.

At each decision point stop to complete the following:

Decision #1

Which decision did you select?

Why did you select this decision? Support your response with evidence and references to the Learning Resources.

What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.

Explain any difference between what you expected to achieve with Decision #1 and the results of the decision. Why were they different?

Decision #2

Why did you select this decision? Support your response with evidence and references to the Learning Resources.

What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.

Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different?

Decision #3

Why did you select this decision? Support your response with evidence and references to the Learning Resources.

What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.

Explain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different?

**Decision #1:**

 

**Decision:** Prescribe acetaminophen (Tylenol) for pain relief.

 

**Reasoning:** Acetaminophen is a commonly used analgesic for mild to moderate pain, such as hip pain. It has a favorable safety profile and is generally well-tolerated by most individuals. Given the client’s presentation with hip pain, starting with acetaminophen is a conservative approach to pain management that avoids the potential risks associated with opioid medications.

 

**Expected Outcome:** By prescribing acetaminophen, the goal is to provide effective pain relief while minimizing the risk of adverse effects, particularly those associated with opioids. Acetaminophen’s mechanism of action involves inhibition of prostaglandin synthesis in the central nervous system, resulting in analgesia without anti-inflammatory effects.

 

**Actual Outcome:** The client experiences mild relief of hip pain with acetaminophen, but the pain persists at a moderate level. While acetaminophen is effective for mild pain, it may not provide sufficient relief for moderate to severe pain, such as that experienced by the client.

 

**Explanation:** The difference between the expected and actual outcomes may be attributed to the severity of the client’s hip pain. Acetaminophen’s efficacy is limited in cases of moderate to severe pain, where stronger analgesics such as nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids may be more appropriate.

 

**Decision #2:**

 

**Decision:** Prescribe ibuprofen (Advil) as an adjunct to acetaminophen for pain relief.

 

**Reasoning:** Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. By adding ibuprofen to the client’s pain management regimen, we aim to enhance pain relief through its anti-inflammatory effects, which may be beneficial for hip pain due to potential inflammation of surrounding tissues.

 

**Expected Outcome:** The combination of acetaminophen and ibuprofen is expected to provide synergistic pain relief, addressing both the nociceptive and inflammatory components of the client’s hip pain. Ibuprofen’s mechanism of action involves inhibition of cyclooxygenase enzymes, reducing the production of prostaglandins responsible for pain and inflammation.

 

**Actual Outcome:** The client experiences significant improvement in pain relief with the combination of acetaminophen and ibuprofen. The synergistic effects of the two medications result in better pain control compared to acetaminophen alone, leading to increased comfort and improved function for the client.

 

**Explanation:** The addition of ibuprofen complements acetaminophen’s analgesic effects by targeting inflammation, which may have contributed to the client’s hip pain. This combination approach aligns with evidence-based recommendations for multimodal pain management and highlights the importance of addressing both nociceptive and inflammatory pathways in pain treatment.

 

**Decision #3:**

 

**Decision:** Refer the client to a pain management specialist for further evaluation and consideration of opioid therapy.

 

**Reasoning:** Despite the initial improvement with acetaminophen and ibuprofen, the client’s hip pain persists at a level that significantly affects daily functioning and quality of life. Referring the client to a pain management specialist allows for a comprehensive assessment of the underlying etiology of the pain and consideration of additional treatment modalities, including opioid therapy, if indicated.

 

**Expected Outcome:** The pain management specialist conducts a thorough evaluation of the client’s hip pain, including diagnostic imaging and functional assessments. Based on the findings, the specialist may recommend opioid therapy as part of a multimodal pain management plan to achieve adequate pain control and improve the client’s overall function and well-being.

 

**Actual Outcome:** The pain management specialist determines that the client’s hip pain is attributable to severe osteoarthritis and recommends a trial of opioid therapy for pain management. The client responds well to opioid treatment, experiencing significant reduction in pain intensity and improved mobility.

 

**Explanation:** The difference between the expected and actual outcomes may stem from the pain management specialist’s expertise in assessing and managing complex pain conditions. By involving a specialist, the client receives individualized care tailored to their specific needs and circumstances, leading to optimal treatment outcomes. The decision to consider opioid therapy reflects a comprehensive approach to pain management that prioritizes the client’s comfort, function, and overall quality of life.

Also include how ethical considerations might impact your treatment plan and communication with clients.

Note: Support your rationale with a minimum of three academic resources. While you may use the course text to support your rationale, it will not count toward the resource requirement.

Complex Regional Pain Disorder
White Male With Hip Pain

BACKGROUND

This week, a 43-year-old white male presents at the office with a chief complaint of pain. He is assisted in his ambulation with a set of crutches. At the beginning of the clinical interview, the client reports that his family doctor sent him for psychiatric assessment because the doctor felt that the pain was “all in his head.” He further reports that his physician believes he is just making stuff up to get “narcotics to get high.”

SUBJECTIVE

The client reports that his pain began about 7 years ago when he sustained a fall at work. He states that he landed on his right hip. Over the years, he has had numerous diagnostic tests done (x-rays, CT scans, and MRIs). He reports that about 4 years ago, it was discovered that the cartilage surrounding his right hip joint was 75% torn (from the 3 o’clock to 12 o’clock position). He reports that none of the surgeons he saw would operate because they felt him too young for a total hip replacement and believed that the tissue would repair with the passage of time. Since then, he reported development of a strange constellation of symptoms including cooling of the extremity (measured by electromyogram). He also reports that he experiences severe cramping of the extremity. He reports that one of the neurologists diagnosed him with complex regional pain syndrome (CRPS), also known as reflex sympathetic dystrophy (RSD). However, the neurologist referred him back to his family doctor for treatment of this condition. He reports that his family doctor said “there is no such thing as RSD, it comes from depression” and this was what prompted the referral to psychiatry. He reports that one specialist he saw a few years ago suggested that he use a wheelchair, to which the client states “I said ‘no,’ there is no need for a wheelchair, I can beat this!”

The client reports that he used to be a machinist where he made “pretty good money.” He was engaged to be married, but his fiancé got “sick and tired of putting up with me and my pain, she thought I was just turning into a junkie.”

He reports that he does get “down in the dumps” from time to time when he sees how his life has turned out, but emphatically denies depression. He states “you can’t let yourself get depressed… you can drive yourself crazy if you do. I’m not really sure what’s wrong with me, but I know I can beat it.”

During the client interview, the client states “oh! It’s happening, let me show you!” this prompts him to stand with the assistance of the corner of your desk, he pulls off his shoe and shows you his right leg. His leg is turning purple from the knee down, and his foot is clearly in a visible cramp as the toes are curled inward and his foot looks like it is folding in on itself. “It will last about a minute or two, then it will let up” he reports. Sure enough, after about two minutes, the color begins to return and the cramping in the foot/toes appears to be releasing. The client states “if there is anything you can do to help me with this pain, I would really appreciate it.” He does report that his family doctor has been giving him hydrocodone, but he states that he uses is “sparingly” because he does not like the side effects of feeling “sleepy” and constipation. He also reports that the medication makes him “loopy” and doesn’t really do anything for the pain.

MENTAL STATUS EXAM

The client is alert, oriented to person, place, time, and event. He is dressed appropriately for the weather and time of year. He makes good eye contact. Speech is clear, coherent, goal directed, and spontaneous. His self-reported mood is euthymic. Affect consistent to self-reported mood and content of conversation. He denies visual/auditory hallucinations. No overt delusional or paranoid thought processes appreciated. Judgment, insight, and reality contact are all intact. He denies suicidal/homicidal ideation, and is future oriented.

Diagnosis: Complex regional pain disorder (reflex sympathetic dystrophy)

Decision Point One

Select what the PMHNP should do:

Savella 12.5 mg orally once daily on day 1; followed by 12.5 mg BID on day 2 and 3; followed by 25 mg BID on days 4-7; followed by 50 mg BID thereafter

Amitriptyline 25 mg po QHS and titrate upward weekly by 25 mg to a max dose of 200 mg per day

Neurontin 300 mg po BEDTIME with weekly increases of 300 mg per day to a max of 2400 mg if needed

The post Analyze factors that influence pharmacokinetic and pharmacodynamic processes in clients requiring therapy for pain appeared first on Destiny Papers.